Lagnaoui Rajaa, Depont Fanny, Fourrier Annie, Abouelfath Abdelillah, Bégaud Bernard, Verdoux Hélène, Moore Nicholas
Département de Pharmacologie, EA 3676, IFR 99, Université Victor Segalen, Bordeaux 2, 33076 Bordeaux, France.
Eur J Clin Pharmacol. 2004 Sep;60(7):523-9. doi: 10.1007/s00228-004-0808-2.
To investigate the prevalence of current use of benzodiazepines (BZDs) and related drugs in the French general population and factors associated with this use.
National cross-sectional telephone survey conducted between 25 April 2001 and 8 May 2001 in a representative sample of non-institutionalized adults of BZD use and duration, prescriber specialty, socio-demographic data and mood and anxiety disorders, using a structured diagnostic interview.
The prevalence of current use of BZD was 7.5%. It was higher among women (9.7%) than men (5.2%). It increased with age and was higher in the jobless (10.9). Duration of BZD use was more than 6 months in 75.9% of users and increased with age. Of the 711 (17.7%) subjects with at least one mood or anxiety disorder, 122 (17%) used BZD compared with 180 (5.5%) of the 3296 subjects without mood or anxiety disorders. In multivariate analysis, factors associated with BZD use were age [odds ratio (OR): 3.6; 95% confidence interval (CI) 2.0-5.6], 6.5 (4.1-10.3) and 10.9 (6.9-17.1), respectively, for ages 35-44 years, 45-59 years and over 60 years compared with below 34 years, female gender (OR: 1.7; 95% CI 1.3-2.1), anxiety only (OR: 2.2; 95% CI 1.5-3.2), mood disorder only (OR: 4.4; 95% CI 2.7-7.1) or both mood and anxiety disorders (OR: 8.8; 95% CI 5.9-12.6).
Despite precautions, warnings and attempts to limit use, there remains a high proportion of long-term BZD users in the general French population, especially in the elderly. Our findings add to the weight of opinion that messages concerning proper use of BZDs certainly need to be clarified and amplified.
调查法国普通人群中当前使用苯二氮䓬类药物(BZD)及相关药物的情况以及与这种使用相关的因素。
于2001年4月25日至2001年5月8日进行全国性横断面电话调查,以非机构化成年人为代表性样本,采用结构化诊断访谈询问BZD的使用情况、使用时长、开处方医生的专业、社会人口统计学数据以及情绪和焦虑障碍情况。
当前使用BZD的患病率为7.5%。女性(9.7%)高于男性(5.2%)。患病率随年龄增长而升高,在失业者中更高(10.9%)。75.9%的使用者使用BZD的时长超过6个月,且随年龄增长而增加。在711名(17.7%)至少患有一种情绪或焦虑障碍的受试者中,122名(17%)使用BZD,而在3296名无情绪或焦虑障碍的受试者中有180名(5.5%)使用BZD。在多变量分析中,与使用BZD相关的因素包括年龄[比值比(OR):3.6;95%置信区间(CI)2.0 - 5.6],35 - 44岁、45 - 59岁和60岁以上人群与34岁以下人群相比,OR分别为6.5(4.1 - 10.3)和10.9(6.9 - 17.1),女性性别(OR:1.7;95% CI 1.3 - 2.1),仅患有焦虑症(OR:2.2;95% CI 1.5 - 3.2),仅患有情绪障碍(OR:4.